Tech Company Financing Transactions
PolyActiva Funding Round
PolyActiva, operating out of Notting Hill, VIC, secured $26 million in funding from Brandon Capital Partners.
Transaction Overview
Company Name
Announced On
6/14/2025
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series C
Investors
Brandon Capital Partners (Chris Nave)
Proceeds Purpose
The financing will also support the continued development of the company's broader pipeline and exploration of new therapeutic opportunities enabled by its proprietary PREZIA platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
45-47 Normanby Road 21
Notting Hill, VIC, 3168
Australia
Notting Hill, VIC, 3168
Australia
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. Our mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vanessa Waddell
Browse more venture capital transactions:
Prev: 6/13/2025: Tombot venture capital transaction
Next: 6/15/2025: Aspora venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs